Ultrasound guided stellate ganglion block for prevention and treatment of acute lung injury

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029336

Enrollment

Unknown

Registered

2020-01-25

Start date

2020-07-01

Completion date

Unknown

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lung injury

Interventions

experimental group:Ultrasound-guided stellate ganglion block

control group:Conventional treatment

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Signed informed consent; 2. Aged 18-100 years; 3. ASA I-III; 4. Effective communicators.

Exclusion criteria

Exclusion criteria: 1. contraindications for ultrasound, include with contraindications for ultrasound; 2. have a history of related drug allergies; 3. Severe mental disorders; 4. history of alcohol or drug addiction.

Design outcomes

Primary

Measure	Time frame
CIRP dynamics;White blood cell and white blood cell classification count;Catechinolamine, pro-inflammatory factor, type I IFN, lactic acid, creatinine, procalcitonin (PCT) levels;	—

Secondary

Measure	Time frame
SOFA (sepsis-related Organ Failure Assessment) and APACHE II (Acute Physiology and Chronic Health Evaluation II) scores;	—

Countries

China

Contacts

Public ContactHe Xingying

Shanghai Changzheng Hospital

2609232704@qq.com+86 13524938636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026